Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-25-000120
Filing Date
2025-07-30
Accepted
2025-07-30 06:02:51
Documents
3
Period of Report
2025-07-30

Document Format Files

Seq Description Document Type Size
1 6-K form-6k_073025.htm 6-K 809849
2 EX-99.1 exhibit991_073025.htm EX-99.1 576342
3 GRAPHIC logo.jpg GRAPHIC 8056
  Complete submission text file 0001395064-25-000120.txt   1398421
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 251163822
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)